The choice of flutamide over other antiandrogens, like bicalutamide or enzalutamide, depends on various factors including side effect profiles, patient tolerance, and specific clinical scenarios. Flutamide is sometimes preferred for its ability to achieve rapid results in reducing androgenic stimulation of cancer cells.
